The Metastatic Cancer Drug Market is expanding steadily as targeted therapies and immunotherapies become central to managing advanced cancers. One widely cited analysis values the global metastatic cancer drugs market at about USD 78.75–80.13 billion in 2024–2025, with forecasts reaching USD 120.8–123.5 billion by 2030–2031, at CAGRs around 7.3–7.5%. Some...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
